{{Rsnum
|rsid=12455924
|Gene=PIEZO2
|Chromosome=18
|position=11064410
|Orientation=plus
|GMAF=0.1373
|Gene_s=PIEZO2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 80.5 | 19.5 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 93.8 | 6.2 | 0.0
| YRI | 34.7 | 51.0 | 14.3
| ASW | 47.4 | 47.4 | 5.3
| CHB | 100.0 | 0.0 | 0.0
| CHD | 98.1 | 1.9 | 0.0
| GIH | 93.1 | 6.9 | 0.0
| LWK | 33.9 | 48.6 | 17.4
| MEX | 87.9 | 12.1 | 0.0
| MKK | 61.9 | 31.0 | 7.1
| TSI | 78.4 | 19.6 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=T
  |Pval=3E-7
  |OR=17.88
  |ORtxt=[11.04-24.72] mg/dL decrease
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}